Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 67877-451

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 67877-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olme-hctz-20-125mg-90-tablets (Olme Hctz 20 125mg 90 Tablets)

Each tablet contains Olmesartan medoxomil and hydrochlorothiazide, with respective amounts of 20 mg and 12.5 mg. The tablets should be stored at a temperature range of 20-25°C (68-77°F), following USP guidelines. The dosing information can be found in the package insert. It is important to keep these tablets and all medications out of reach of children. This specific product is manufactured by Alkem Laboratories Ltd in Mumbai, India, and distributed by Ascend Laboratories LLC in Parsippany, NJ. The tablets are identified by the NDC number 67877-453-90.*

FDA Label Image

Olme-hctz-40-125mg-90 Tablets (Olme Hctz 40 125mg 90 Tablets)

Each tablet is a combination of Olmesartan medoxomil (40 mg) and hydrochlorothiazide (12.5 mg). This medication is used for a specific purpose mentioned in the package insert. It should be stored in a cool and dry place at a temperature range of 20 to 25°C. Keep the tablets out of the reach of children. The manufacturer is Alkem Laboratories Ltd., based in Mumbai, India, and the distribution is handled by Ascend Laboratories, LLC, located in Parsippany, NJ. The pack contains 90 tablets.*

FDA Label Image

Olme-hctz-40-25mg-30 Tablets (Olme Hctz 40 25mg 30 Tablets)

This text provides information about a medication containing Olmesartan medoxonil and hydrochlorothiazide. Each tablet contains 40 mg of Olmesartan medoxonil and 25 mg of hydrochlorothiazide. It includes storage instructions and manufacturing details. Dosage and usage instructions should be checked in the package insert. The medication should be kept out of reach of children. This product is distributed by Ascend Laboratories and manufactured by Alkem Laboratories in Mumbai, India. The NDC for this medication is 67877-451-30.*

FDA Label Image

Hctz-str-2 (Olme Hctz Str 2)

FDA Label Image

Olmesartan-str-1 (Olme Olmesartan Str 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.